DaVita (MEX:DVA) Marketable Securities: MXN402 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DVA DaVita Inc MEX:DVA
75 GF Score
Price MXN3,358.09
GF Value MXN2,499.46
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Marketable Securities?

DaVita MEX:DVA 75 Marketable Securities is MXN402 Mil as of Mar. 2026. GuruFocus rates MEX:DVA with a GF Score™ of 75/100 and a GF Value™ of MXN2,499.46 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. DaVita's Marketable Securities for the quarter that ended in Mar. 2026 was MXN402 Mil.

DaVita's annual Marketable Securities increased from Dec. 2023 (MXN197 Mil) to Dec. 2024 (MXN1,065 Mil) but then declined from Dec. 2024 (MXN1,065 Mil) to Dec. 2025 (MXN438 Mil).

DaVita  (MEX:DVA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

DaVita Marketable Securities Related Terms

DaVita Marketable Securities Historical Data

* Premium members only.

The historical data trend for DaVita's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Marketable Securities Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 457.67 1,514.70 197.07 1,064.98 437.59

DaVita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,496.78 583.97 559.94 437.59 402.18
MEX:DVA
75GF Score
DaVita Inc MEX:DVA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of MXN402 Mil mean?
DaVita (MEX:DVA) has a Marketable Securities of MXN402 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on DaVita and its competitors.
Is DaVita's Marketable Securities too high?
DaVita's current Marketable Securities is MXN402 Mil. Overall, DaVita has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Marketable Securities compare to THC and EHC?
DaVita's Marketable Securities of MXN402 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on DaVita and its competitors. DaVita's current Marketable Securities is MXN402 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MEX:DVA) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN2,499.46, compared to a current price of MXN3,358.09 — trading 34.4% above its estimated fair value. The current Marketable Securities is MXN402 Mil. DaVita's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For DaVita (MEX:DVA), the current Marketable Securities is MXN402 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (MEX:DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of MXN3,358.09 is trading 34.4% above its estimated GF Value™ of MXN2,499.46. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for MEX:DVA:

  • Marketable Securities: MXN402 Mil
  • GF Value™: MXN2,499.46 vs. price of MXN3,358.09 (34.4% above fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the MEX:DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
75GF Score

Get the complete analysis for MEX:DVA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,358.09
Price
MXN2,499.46
GF Value